Literature DB >> 1483492

Menstrual cycle effects on caffeine elimination in the human female.

J D Lane1, J F Steege, S L Rupp, C M Kuhn.   

Abstract

Increases in the levels of sex steroids due to pregnancy or oral contraceptive steroid use are known to decrease significantly the rate at which caffeine is eliminated from the body. An investigation has now been made into whether the changes in sex steroid levels that occur during normal menstrual cycling also affect the rate of caffeine elimination, especially whether hormonal shifts in the luteal phase are associated with slower elimination of caffeine. Repeated 24-hour caffeine elimination studies were conducted during the follicular and luteal phases of the menstrual cycle in 10 healthy women. Comparisons of the follicular and luteal phases revealed that systemic clearance of caffeine was slower in the luteal phase, although the t1/2 did not differ. The slowing effect was related to the proximity to onset of menstruation and to levels of progesterone. The evidence suggests that caffeine elimination may be slowed in the late luteal phase, prior to the onset of menstruation. Such a reduction would lead to increased accumulation of caffeine with repeated self-administration during the day, but the effect may be too small to be of clinical significance in the majority of women.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483492     DOI: 10.1007/bf02285099

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Anxiety or caffeinism: a diagnostic dilemma.

Authors:  J F Greden
Journal:  Am J Psychiatry       Date:  1974-10       Impact factor: 18.112

2.  Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine.

Authors:  M M Callahan; R S Robertson; A R Branfman; M F McComish; D W Yesair
Journal:  Drug Metab Dispos       Date:  1983 May-Jun       Impact factor: 3.922

3.  Caffeine in plasma and saliva by a radioimmunoassay procedure.

Authors:  C E Cook; C R Tallent; E W Amerson; M W Myers; J A Kepler; G F Taylor; H D Christensen
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

4.  Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids.

Authors:  E C Rietveld; M M Broekman; J J Houben; T K Eskes; J M van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.

Authors:  D R Abernethy; E L Todd
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  The disposition of caffeine during and after pregnancy.

Authors:  A Aldridge; J Bailey; A H Neims
Journal:  Semin Perinatol       Date:  1981-10       Impact factor: 3.300

7.  [Elimination of caffeine and metamizole in the menstrual cycle of the fertile female].

Authors:  A Balogh; E Irmisch; G Klinger; F K Splinter; A Hoffmann
Journal:  Zentralbl Gynakol       Date:  1987

8.  Impaired elimination of caffeine by oral contraceptive steroids.

Authors:  R V Patwardhan; P V Desmond; R F Johnson; S Schenker
Journal:  J Lab Clin Med       Date:  1980-04
  8 in total
  43 in total

Review 1.  Novel insights on caffeine supplementation, CYP1A2 genotype, physiological responses and exercise performance.

Authors:  Gabriel Barreto; Beatriz Grecco; Pietro Merola; Caio Eduardo Gonçalves Reis; Bruno Gualano; Bryan Saunders
Journal:  Eur J Appl Physiol       Date:  2021-01-05       Impact factor: 3.078

Review 2.  CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: a systematic review.

Authors:  Jozo Grgic; Craig Pickering; Juan Del Coso; Brad J Schoenfeld; Pavle Mikulic
Journal:  Eur J Nutr       Date:  2020-11-02       Impact factor: 5.614

3.  Increased spinal excitability does not offset central activation failure.

Authors:  J M Kalmar; C Del Balso; E Cafarelli
Journal:  Exp Brain Res       Date:  2006-02-28       Impact factor: 1.972

Review 4.  Effects of Caffeine on Resistance Exercise: A Review of Recent Research.

Authors:  Jozo Grgic
Journal:  Sports Med       Date:  2021-07-22       Impact factor: 11.136

Review 5.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

6.  Cardiovascular responses to caffeine by gender and pubertal stage.

Authors:  Jennifer L Temple; Amanda M Ziegler; Adam Graczyk; Ashley Bendlin; Teresa Sion; Karina Vattana
Journal:  Pediatrics       Date:  2014-06-16       Impact factor: 7.124

7.  Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women.

Authors:  Charles E Frost; John Adams; Mark Shelton; Abdel-Hameed I Mohammed Ebid; Lawrence J Gugino; Ross Hewitt; Robin Difrancesco; Elizabeth Ingalls; Stephen Cousins; J Hu; Gene D Morse
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

8.  Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.

Authors:  Monica Rodriguez; M Angeles Carlos; Ignacio Ortega; Elena Suarez; Rosario Calvo; John C Lukas
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

Review 9.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 10.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.